138 related articles for article (PubMed ID: 37523068)
1. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
Peng S; Yu J; Wang Y
Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
[TBL] [Abstract][Full Text] [Related]
2. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
[TBL] [Abstract][Full Text] [Related]
3. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
4. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
[TBL] [Abstract][Full Text] [Related]
5. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma.
Zhang T; Shi W; Tian K; Kong Y
World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353
[TBL] [Abstract][Full Text] [Related]
6. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
Cai Y; Wu D; Zhan L
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
[TBL] [Abstract][Full Text] [Related]
7. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
Peng W; Li W; Zhang X; Cen W; Liu Y
J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
[TBL] [Abstract][Full Text] [Related]
8. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Wang N; Chen Y; Wu J
Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
[TBL] [Abstract][Full Text] [Related]
9. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.
Huang K; Zeng Y; Xie Y; Huang L; Wu Y
Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452
[TBL] [Abstract][Full Text] [Related]
11. Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
Sun H; Wang Y; Jing HY; Yang XY; Shi XX; Zhang JH; Yu YX; Gao L; Wang XY; Li WH; Yu L
Front Genet; 2021; 12():629856. PubMed ID: 34017352
[TBL] [Abstract][Full Text] [Related]
12. CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma.
Wang H; Wang X; Xu L; Lin Y; Zhang J
Dis Markers; 2022; 2022():1560199. PubMed ID: 35937942
[TBL] [Abstract][Full Text] [Related]
13. CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro.
Zeng W; Wu M; Cheng Y; Liu L; Han Y; Xie Q; Li J; Wei L; Fang Y; Chen Y; Peng J; Shen A
PLoS One; 2022; 17(12):e0279851. PubMed ID: 36584147
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway.
Li B; Lu X; Ma C; Sun S; Shu X; Wang Z; Sun W
Neurosci Lett; 2020 Jul; 732():135086. PubMed ID: 32454145
[TBL] [Abstract][Full Text] [Related]
15. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
[TBL] [Abstract][Full Text] [Related]
17. Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma.
Zeng G; Wang J; Huang Y; Lian Y; Chen D; Wei H; Lin C; Huang Y
Onco Targets Ther; 2019; 12():10427-10439. PubMed ID: 31819524
[TBL] [Abstract][Full Text] [Related]
18. HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A.
Yang X; Tong Y; Ye W; Chen L
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35315492
[TBL] [Abstract][Full Text] [Related]
19. Downregulated circular RNA itchy E3 ubiquitin protein ligase correlates with advanced pathologic T stage, high lymph node metastasis risk and poor survivals in prostate cancer patients.
Huang E; Chen X; Yuan Y
Cancer Biomark; 2019; 26(1):41-50. PubMed ID: 31306101
[TBL] [Abstract][Full Text] [Related]
20. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
